amprionme.com
Get leads like Amprionme — and thousands more
Build targeted lists by tech stack, and more
Amprion: The Silent Biotech Behind Parkinson's Diagnosis
A 44-person team tackling a $20B market with a single patented test
In the $20B neurodegenerative diagnostics market, Amprion is quietly building a moat around alpha-synuclein testing. With a team of just 44 and $6.8M in revenue, they're not chasing hype—they're solving a fundamental diagnostic problem that has eluded medicine for decades.
"They're not building a website for traffic—they're building a diagnostic platform for clinical impact."
The Core Problem They Solve
Parkinson's disease and related synucleinopathies are notoriously difficult to diagnose early. Current methods rely on clinical observation, which can be subjective and often comes years after irreversible damage has occurred. Amprion's SAAmplify-α-SYN test detects pathological alpha-synuclein in biofluids, potentially enabling diagnosis years before symptoms manifest. This isn't incremental improvement—it's a paradigm shift from symptom-based to biomarker-based diagnosis.
The Real Customer Base
Amprion's B2B2C model targets clinical labs and neurologists, not direct consumers. With a lean team of 44, they're focused on the 6 million Americans living with Parkinson's and the 90,000 new cases annually. Their contact email ([email protected]) suggests a focused outbound strategy rather than mass-market digital acquisition. The zero traffic to amprionme.com isn't a failure—it's a strategic choice to allocate resources to R&D and clinical validation, not SEO.
The tech stack reveals their priorities: Webflow for a lightweight, maintainable site; jQuery and Tailwind for efficiency; Google Analytics for tracking the few who do visit. No complex CMS, no aggressive content marketing. This is a company that knows its website is a brochure, not a product. The real product is the SAAmplify-α-SYN test, and the real market is the clinical laboratory network.
- Patented SAAmplify-α-SYN test for alpha-synuclein detection
- Focus on cognitive and movement disorders beyond just Parkinson's
- Clinical laboratory operations led by J Lamoureux, Sr. Director
- Regulatory expertise through EVP Karen MacLeod
- Scientific foundation from CSO & Co-Founder Claudio Soto
The Silent Giant Strategy
Amprion is building a diagnostic empire one clinical validation at a time, while competitors chase venture capital headlines.
What tech stack does Amprionme use?
How much traffic does Amprionme get?
Traffic & Engagement
How is Amprionme's SEO?
Open Graph Image
https://cdn.prod.website-files.com/67eb1c09a3ca76422bf30734/68703d18b7a3a0736098273e_og-image.jpg
Meta Tags
Amprion | Amprion Diagnostics
Amprion Diagnostics is a leader in alpha-synuclein testing, with its patented SAAmplify-𝛼-SYN test for a range of cognitive and movement disorders.
H1 Tags
What is Amprionme's revenue?
Who works at Amprionme?
Loading leads...
What do customers think of Amprionme?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Amprionme
What is Amprionme's Revenue?
What does Amprionme do?
How fast is Amprionme growing?
What technologies does Amprionme use?
Who are Amprionme's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Amprionme?
Contact Information
Export amprionme.com Data
Download the complete tech stack, analytics, leads, and company data for amprionme.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About amprionme.com
Amprion Diagnostics is a leader in alpha-synuclein testing, with its patented SAAmplify-𝛼-SYN test for a range of cognitive and movement disorders.
Company Overview
amprionme.com Social Media
Contact amprionme.com
Email Addresses
Phone Numbers
Technology Stack
amprionme.com uses 11 technologies across their website including Google Fonts, Webflow, AWS CloudFront, and more.
Fonts
Google Fonts
CMS
Webflow
Cloud & Hosting
AWS CloudFront
Analytics & Marketing
Google Analytics
Performance
Lazy Loading
Web Standards
Twitter Cards
Traffic & Audience
amprionme.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is amprionme.com?
What technologies does amprionme.com use?
How do I contact amprionme.com?
What are amprionme.com's social media accounts?
Is amprionme.com hiring?
How popular is amprionme.com?
Related Searches
This page provides publicly available information about amprionme.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit amprionme.com directly at https://amprionme.com.